二甲双胍治疗对多囊卵巢综合征孕妇的免疫调节作用
该研究是对PregMet和PregMet2两项随机对照试验的事后分析,纳入615名多囊卵巢综合征孕妇的纵向血清样本,从孕早期至分娩随机接受二甲双胍或安慰剂。结果显示二甲双胍与多种多功能细胞因子血清水平升高相关,最强效应见于嗜酸性粒细胞趋化因子(P<.001)、白细胞介素-17(P=.03)和碱性成纤维细胞生长因子(P=.04),且免疫调节作用在正常体重和超重女性中强于肥胖女性。结论认为二甲双胍在孕期具有免疫调节而非抗炎特性。
要点
- 二甲双胍与孕期多种多功能细胞因子血清水平升高相关,最强效应为嗜酸性粒细胞趋化因子(P<.001)。
- 免疫调节作用在正常体重和超重女性中强于肥胖女性。
- 正常雄激素女性孕早期效应最强,高雄激素女性效应贯穿整个孕期。
核心结论
- 二甲双胍在孕期似乎具有免疫调节而非抗炎特性。
- 其对多种多功能细胞因子血清水平的影响显示稳健、持续且依赖体重的免疫动员。
研究设计与样本
- 对PregMet和PregMet2两项随机对照试验进行事后分析,纳入615名多囊卵巢综合征孕妇的纵向母体血清样本。
- 女性从孕早期至分娩随机接受二甲双胍或安慰剂。
- 在孕5至12周、19周、32周和36周采集血清,检测22种细胞因子和C反应蛋白。
主要发现
- 二甲双胍治疗与整个孕期多种多功能细胞因子血清水平升高相关,最强效应为嗜酸性粒细胞趋化因子(P<.001)、白细胞介素-17(P=.03)和碱性成纤维细胞生长因子(P=.04)。
- 联合细胞因子发展评估证实二甲双胍对22种细胞因子中的一半有影响。
- 二甲双胍的免疫调节作用在正常体重和超重女性中比在肥胖女性中更强。
- 正常雄激素女性在孕早期二甲双胍效应最强,而高雄激素女性在整个孕期呈现递增效应。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Polycystic ovary syndrome (PCOS) is a common endocrine disorder associated with low-grade systemic inflammation and increased risk of pregnancy complications. Metformin treatment reduces the risk of late miscarriage and preterm birth in pregnant women with PCOS. Whether the protective effect of metformin involves immunological changes has not been determined. OBJECTIVE: To investigate the effect of metformin on the maternal immunological status in women with PCOS. METHODS: A post-hoc analysis was performed of two randomized controlled trials, PregMet and PregMet2, including longitudinal maternal serum samples from 615 women with PCOS. Women were randomized to metformin or placebo from first trimester to delivery. Twenty-two cytokines and C-reactive protein were measured in serum sampled at gestational weeks 5 to 12, 19, 32, and 36. RESULTS: Metformin treatment was associated with higher serum levels of several multifunctional cytokines throughout pregnancy, with the strongest effect on eotaxin (P < .001), interleukin-17 (P = .03), and basic fibroblast growth factor (P = .04). Assessment of the combined cytokine development confirmed the impact of metformin on half of the 22 cytokines. The immunomodulating effect of metformin was more potent in normal weight and overweight women than in obese women. Moreover, normoandrogenic women had the strongest effect of metformin in early pregnancy, whereas hyperandrogenic women presented increasing effect throughout pregnancy. CONCLUSION: It appears that metformin has immunomodulating rather than anti-inflammatory properties in pregnancy. Its effect on the serum levels of many multifunctional cytokines demonstrates robust, persisting, and body mass-dependent immune mobilization in pregnant women with PCOS.
引用
- Ryssdal M, Vanky E, Stokkeland LMT, et al. Immunomodulatory Effects of Metformin Treatment in Pregnant Women With PCOS. J Clin Endocrinol Metab. 2023. PMID: 36916886. doi:10.1210/clinem/dgad145
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。